Position in VCEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19,575,154
+$7,971,050 QoQ
Shares Held
439,990
+22.0% QoQ
Ownership
0.859%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#33
of 317 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SEI INVESTMENTS CO holds $1,273,690,748 across 210 Biotechnology names. VCEL ranks #16 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
255,073 | $236,649,076 | |
| 2 | INSM |
INSMED Inc
|
1,015,870 | $108,312,059 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
129,981 | $64,565,461 | |
| 4 | EXEL |
Exelixis, Inc.
|
1,166,715 | $63,480,962 | |
| 5 | ASND |
Ascendis Pharma A/S
|
237,869 | $63,444,419 | |
| 6 | INCY |
Incyte Corp
|
498,013 | $56,454,752 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
551,116 | $43,135,848 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
60,441 | $37,687,380 |
All Filings in VCEL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,575,154 | 439,990 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,604,104 | 360,712 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $8,362,169 | 232,218 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,491,033 | 206,261 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $9,446,056 | 221,999 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,558,956 | 57,350 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,291,579 | 59,945 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,757,446 | 65,265 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,850,936 | 62,139 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,566,666 | 49,340 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $1,176,126 | 33,028 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,702,319 | 140,284 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,833,567 | 102,038 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,084,781 | 36,998 | Shares | Sole | 2023-05-12 | |
| 2022-09-30 | $2,460,058 | 106,037 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,573,542 | 221,348 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $460,436 | 12,047 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $233,835 | 5,950 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $900,457 | 18,452 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,219,384 | 42,274 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $2,167,616 | 39,021 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $992,482 | 32,140 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $203,273 | 10,970 | Shares | Sole | 2020-12-04 | |
| 2020-06-30 | $155,557 | 11,256 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $139,538 | 15,217 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||